Image of the Day: Brainless Frogs

Without a brain, the frog embryo immune system doesn’t receive the signals it needs to mobilize macrophages and fight infections.

Written byAmy Schleunes
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: The tail of a brainless frog embryo shows an abnormal distribution of immune cells (green) and a haphazard network of nerves (red).
C. HERRERA-RINCON ET AL., NPJ REGENERATIVE MEDICINE, DOI:10.1038/S41536-020-0087-2, 2020

Developing frog embryos without brains die of E. coli infections at higher rates than embryos with brains, report the authors of a study published on February 5 in npj Regenerative Medicine. The brain appears to send signals to the embryo’s nascent immune system, which results in macrophages moving to the site of an infection, according to a press release.

“Our results demonstrate the deep interconnections within the bacteria-brain-body axis: the early brain is able to ‘sense’ the pathogenic bacteria and to elaborate a response targeted to fight against the cellular and molecular consequences of the infection,” says coauthor Celia Herrera-Rincon of Tufts University in the statement.

C. Herrera-Rincon et al., “An in vivo brain-bacteria interface: the developing brain as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies